Quell Therapeutics’ Post

Interested in learning how the battle against Alzheimer's is going (spoiler alert: we are making a ton of progress)? In our upcoming webinar, two experts will discuss the evolving clinical and investment landscape in Alzheimer's disease. This a great chance to hear how VCs and clinicians are thinking about the space. Registration link below. #alzheimersdisease

Join us this afternoon at 4:00 PM EST for an insightful session. Our distinguished speakers will delve deep into the significance of this groundbreaking observational trial. Don't miss this opportunity to be part of a pivotal discussion shaping the future of psychedelic-assisted therapies RSVP Here: https://bit.ly/47dNpQ9 #webinar #psychedelics #mdma #mdxx #psychedelicscience

Trivia is the plural of the Latin word trivium, meaning “a place where three roads meet” i.e., a crossroad. Every other week EpicentRx team members gather not at a place where three roads meet but virtually on Zoom where host and moderator, Dr. Tony Reid, CEO of EpicentRx, presents company-related information and asks fun and interesting questions. These questions prove that not all trivia is trivial, as they most often relate to lead therapies, RRx-001 (nibrozetone) and AdAPT-001. Read more in this blog post here: bit.ly/3x2Yp5C

Introducing Wisdom Wednesday: Elevate your Intelligence 💡 This Alzheimer's Awareness Month 💜 , join us as we shed light on unlocking regulatory intelligence for this vital therapeutic area. With our platform, you can: 1️⃣ Effortlessly search through thousands of approved products and clinical trials with one intuitive workflow. 2️⃣ Search any indication to discover products that have received "expedited pathways." 3️⃣ Quickly recreate a competitor's clinical development plan and see which trials may have led to approval with RIA's CDP module! 4️⃣ RIA offers quick access to vital Clinical Trials Data. Stay at the forefront of the ever-evolving drug development landscape. Schedule a call with us to learn more. ➡ 📞 https://vivpro.ai/contact #AlzheimersAwareness #RegulatoryIntelligence #DrugDevelopment #WisdomWednesday #Vivpro #MorePowerToYou

Cannot agree more

Today, on World Parkinson's Day, we at Prevail Therapeutics pause to reflect on the journey towards empowering those affected by #ParkinsonsDisease (PD).   PD presents unique challenges, impacting millions worldwide. Yet, through our dedication to research and development, we strive to redefine the possibilities for patients and caregivers alike. Our team continues to push the boundaries of science, harnessing new technologies and novel therapeutic approaches to address the complexities of PD. Prevail understands the importance of collaboration and community in combating PD.   At Prevail, we're deeply committed to developing innovative solutions for those with PD. By partnering with healthcare professionals, advocacy groups, and patients themselves, we're forging a united front against Parkinson's, empowering individuals with knowledge, support, and access to advanced treatments.   Together, let's continue to raise awareness, drive innovation, and inspire hope for the Parkinson’s community. To discover more about Prevail’s work with PD, visit our website: https://bit.ly/3QvAYbk #ParkinsonsAwareness #WorldParkinsonsDay

Please read our article on Dr. Janice Kim and her thoughts on #breastcancer screenings, clinical trials, #protontherapy and more: https://lnkd.in/gcvzh_PP

The Future of Healthcare: Digital Therapeutics in Clinical Research The integration of digital therapeutics in clinical research is a game-changer! Learn how these software-based interventions are enhancing patient engagement, improving data collection, and driving better health outcomes. Read our new blog to find out more. #HealthcareInnovation #DigitalTherapeutics #ClinicalTrials

🔊 Listen to Dr. Mark Murcko in our Inaugural 2024 Kitchen Table Talk! Dewpoint scientists hosted experienced drug-hunter Dr. Mark Murcko to kick off our 2024 Kitchen Table Talk series. Dr. Murcko delves into the evolution of drug discovery strategies and how adopting a condensate mindset can transform the way we develop future therapies. Check out the audiogram below for a glimpse into the discussion, and learn how insights into aberrant #condensates and their relationship to disease are reshaping our understanding of disease mechanisms and strategies for drug discovery. 👉 Watch the full discussion here: https://bit.ly/3VB9Dak #DiscoverCondensates

🧠 Our latest research paper is out now in BMJ Innovations. The results show how Limbic Access creates clinical efficacy and improves treatment outcomes in NHS Talking Therapies. 📓 Flip through a breakdown of the key takeaways and learn more about the scope of our study.